1. Home
  2. FSEA vs CLGN Comparison

FSEA vs CLGN Comparison

Compare FSEA & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FSEA
  • CLGN
  • Stock Information
  • Founded
  • FSEA 1890
  • CLGN 2004
  • Country
  • FSEA United States
  • CLGN Israel
  • Employees
  • FSEA N/A
  • CLGN N/A
  • Industry
  • FSEA Savings Institutions
  • CLGN Industrial Specialties
  • Sector
  • FSEA Finance
  • CLGN Health Care
  • Exchange
  • FSEA Nasdaq
  • CLGN Nasdaq
  • Market Cap
  • FSEA 44.0M
  • CLGN 44.1M
  • IPO Year
  • FSEA N/A
  • CLGN N/A
  • Fundamental
  • Price
  • FSEA $9.14
  • CLGN $4.19
  • Analyst Decision
  • FSEA
  • CLGN Strong Buy
  • Analyst Count
  • FSEA 0
  • CLGN 2
  • Target Price
  • FSEA N/A
  • CLGN $12.50
  • AVG Volume (30 Days)
  • FSEA 6.2K
  • CLGN 18.1K
  • Earning Date
  • FSEA 11-08-2024
  • CLGN 11-27-2024
  • Dividend Yield
  • FSEA N/A
  • CLGN N/A
  • EPS Growth
  • FSEA N/A
  • CLGN N/A
  • EPS
  • FSEA N/A
  • CLGN N/A
  • Revenue
  • FSEA $11,390,000.00
  • CLGN $689,000.00
  • Revenue This Year
  • FSEA N/A
  • CLGN N/A
  • Revenue Next Year
  • FSEA N/A
  • CLGN $670.03
  • P/E Ratio
  • FSEA N/A
  • CLGN N/A
  • Revenue Growth
  • FSEA N/A
  • CLGN N/A
  • 52 Week Low
  • FSEA $6.25
  • CLGN $3.61
  • 52 Week High
  • FSEA $9.49
  • CLGN $6.99
  • Technical
  • Relative Strength Index (RSI)
  • FSEA 50.72
  • CLGN 51.28
  • Support Level
  • FSEA $9.00
  • CLGN $3.61
  • Resistance Level
  • FSEA $9.35
  • CLGN $4.39
  • Average True Range (ATR)
  • FSEA 0.12
  • CLGN 0.23
  • MACD
  • FSEA 0.00
  • CLGN 0.09
  • Stochastic Oscillator
  • FSEA 40.00
  • CLGN 59.79

About FSEA First Seacoast Bancorp Inc.

First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities and bank-owned life insurance.

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.

Share on Social Networks: